000 01381 a2200409 4500
005 20250517205822.0
264 0 _c20190807
008 201908s 0 0 eng d
022 _a1945-4589
024 7 _a10.18632/aging.101401
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeiss, Roxanne
245 0 0 _aMetformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice.
_h[electronic resource]
260 _bAging
_c03 2018
300 _a386-401 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAging
_xdrug effects
650 0 4 _aAnimals
650 0 4 _aFemale
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aGlucose Intolerance
_xchemically induced
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aImmunosuppressive Agents
_xtoxicity
650 0 4 _aMale
650 0 4 _aMetformin
_xpharmacology
650 0 4 _aMice
650 0 4 _aRandom Allocation
650 0 4 _aSex Factors
650 0 4 _aSirolimus
_xtoxicity
700 1 _aFernandez, Elizabeth
700 1 _aLiu, Yuhong
700 1 _aStrong, Randy
700 1 _aSalmon, Adam B
773 0 _tAging
_gvol. 10
_gno. 3
_gp. 386-401
856 4 0 _uhttps://doi.org/10.18632/aging.101401
_zAvailable from publisher's website
999 _c28218635
_d28218635